DIVISLAB - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 3.6

📊 Technical & Momentum Overview

✅ Strengths

Price Action: Trading above 200 DMA (₹6,045), but slightly below 50 DMA (₹6,232)—trend is stabilizing.

Volume Surge: Current volume is ~34% higher than 1-week average—momentum supported.

Zero Debt: Strong balance sheet adds margin of safety.

ROCE (20.6%) & ROE (15.6%): Solid capital efficiency.

EPS (₹88.0) vs Industry PE (33.4): Premium valuation, but backed by quality earnings.

FII Inflow (+1.73%): Foreign institutions accumulating.

Qtr Profit Growth (+29.5%): Sequential earnings momentum.

⚠️ Weaknesses

MACD (–58.0): Bearish divergence—momentum fading.

RSI (48.1): Neutral-bearish zone, indicating indecision.

P/E (69.4) vs Industry PE (33.4): Valuation is stretched.

PEG (–7.54): Negative PEG suggests unreliable growth valuation.

DII Outflow (–1.67%): Domestic institutions reducing exposure.

52W Index (54.3%): Mid-range performance—no breakout confirmation.

Broker consensus targets suggest a short-term upside to ₹6,414, with bullish projections reaching ₹6,942–₹7,100 by year-end depending on macro conditions

1

2

.

🎯 Optimal Entry Price

Buy Zone: ₹6,030–₹6,070 (near 200 DMA and VWAP)

Momentum Entry: ₹6,240–₹6,260 if RSI crosses 52 and MACD flattens

🚪 Exit Strategy (If Already Holding)

Target Exit: ₹6,400–₹6,500 (next resistance zone and brokerage target)

Stop Loss: ₹5,920 (below 200 DMA and recent support)

Exit Trigger: RSI dips below 45 or MACD diverges further

Selva, DIVISLAB is a technically cautious but fundamentally robust swing candidate. If you're building a pharma basket or want alert logic for MACD reversal and RSI breakout, I can help you script it.

1

dailybulls.in

2

trendlyne.com

Edit in a page